|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Stock-based compensation | |||||
| Depreciation and amortization | |||||
| Loss (gain) on disposal of property and equipment | |||||
| Other expense (income), net | |||||
| Income from operations | |||||
| Non-operating income and expenses | |||||
| Income (loss) from investments | |||||
| Interest expense, net | |||||
| Net income before taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Net income attributable to noncontrolling interest | |||||
| Net income attributable to Viemed Healthcare, Inc. | |||||
| Change in unrealized gain on derivative instruments, net of tax | |||||
| Comprehensive income | |||||
| Net income per share | |||||
| Basic (in USD per share) | |||||
| Diluted (in USD per share) | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
